Showing results (51-60 of 318) with videos related to
Sort By:
Pageof 32
Molecular Aspects of Medicine|March 20, 2013
Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52Atsushi Yonezawa, Ken-ichi InuiDrug Metabolism and Pharmacokinetics|December 25, 2004
Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulationToshiya Katsura, Ken-Ichi InuiThe AAPS Journal|February 26, 2013
Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidneyHideyuki Motohashi, Ken-ichi InuiGan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[Role of UGT1A1*28 and UGT1A1*6 for irinotecan-induced adverse drug reaction]Masahide Onoue, Ken-ichi InuiBiochemical Pharmacology|November 2, 2005
Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tractTomohiro Terada, Yutaka Shimada, Xiaoyue Pan, et al.Clinical Lung Cancer|July 22, 2011
Plasma and pleural fluid pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small-cell lung cancer with pleural effusionKatsuhiro Masago, Yosuke Togashi, Masahide Fukudo, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2008
Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injuryTakanobu Matsuzaki, Takafumi Morisaki, Wakako Sugimoto, et al.Pharmaceutical Research|October 26, 2005
Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritisYuji Sakurai, Hideyuki Motohashi, Ken Ogasawara, et al.Clinical Pharmacokinetics|March 28, 2013
Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancerMasahide Fukudo, Yasuaki Ikemi, Yosuke Togashi, et al.The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
Transport mechanisms of nicotine across the human intestinal epithelial cell line Caco-2Atsuko Fukada, Hideyuki Saito, Ken-Ichi InuiPageof 32